Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jessie L. Reed"'
Autor:
Emily J. Koubek, Jillian S. Weissenrieder, Luz E. Ortiz, Nnenna Nwogu, Alexander M. Pham, J. Dylan Weissenkampen, Jessie L. Reed, Jeffrey D. Neighbors, Raymond J. Hohl, Hyun Jin Kwun
Publikováno v:
Viruses, Vol 14, Iss 9, p 1848 (2022)
Merkel cell carcinoma (MCC) is a rare but aggressive form of skin cancer predominantly caused by the human Merkel cell polyomavirus (MCPyV). Treatment for MCC includes excision and radiotherapy of local disease, and chemotherapy or immunotherapy for
Externí odkaz:
https://doaj.org/article/14286ce877a24c61b16ace6b7873e807
Autor:
Jillian S. Weissenrieder, Jessie L. Reed, George‐Lucian Moldovan, Martin T. Johnson, Mohamed Trebak, Jeffrey D. Neighbors, Richard B. Mailman, Raymond J. Hohl
Publikováno v:
Pharmacology Research & Perspectives, Vol 9, Iss 3, Pp n/a-n/a (2021)
Abstract Dopamine D2‐like receptor antagonists have been suggested as being potential anticancer therapeutics with specific utility for central nervous system cancers due to their ability to cross the blood‐brain barrier. Despite a plethora of da
Externí odkaz:
https://doaj.org/article/35708c35af8346ed9b57a5f5a2acf42d
Autor:
Jeffrey D. Neighbors, Michelle V. Green, Jillian S. Weissenrieder, Jessie L. Reed, Emily J. Koubek, Raymond J. Hohl, George Lucian Moldovan
Publikováno v:
Pharmacology. 105:19-27
Background: Glioblastoma multiforme (GBM) is a common and lethal cancer of the central nervous system. This cancer is difficult to treat because most anticancer therapeutics do not readily penetrate into the brain due to the tight control at the cere
Autor:
Jeffrey D. Neighbors, Raymond J. Hohl, Jillian S. Weissenrieder, George Lucian Moldovan, Mohamed Trebak, Martin Johnson, Jessie L. Reed, Richard B. Mailman
Publikováno v:
Pharmacology Research & Perspectives, Vol 9, Iss 3, Pp n/a-n/a (2021)
Dopamine D2‐like receptor antagonists have been suggested as being potential anticancer therapeutics with specific utility for central nervous system cancers due to their ability to cross the blood‐brain barrier. Despite a plethora of data report
Autor:
Jillian S, Weissenrieder, Jessie L, Reed, George-Lucian, Moldovan, Martin T, Johnson, Mohamed, Trebak, Jeffrey D, Neighbors, Richard B, Mailman, Raymond J, Hohl
Publikováno v:
Pharmacology Research & Perspectives
Dopamine D2‐like receptor antagonists have been suggested as being potential anticancer therapeutics with specific utility for central nervous system cancers due to their ability to cross the blood‐brain barrier. Despite a plethora of data report
Autor:
Jeffrey D. Neighbors, Patricia J. McLaughlin, Michelle B. Titunick, David F. Wiemer, David P. Stockdale, Alyssa M. Hartung, Jessie L. Reed, Jessica M. Biegler
Publikováno v:
Bioorganic & Medicinal Chemistry. 25:4464-4474
As part of an ongoing drug development effort aimed at selective opioid receptor ligands based on the pawhuskin natural products we have synthesized a small set of amide isosteres. These amides were centered on lead compounds which are selective anta
Autor:
Jillian S, Weissenrieder, Jessie L, Reed, Michelle V, Green, George-Lucian, Moldovan, Emily J, Koubek, Jeffrey D, Neighbors, Raymond J, Hohl
Publikováno v:
Pharmacology. 105(1-2)
Glioblastoma multiforme (GBM) is a common and lethal cancer of the central nervous system. This cancer is difficult to treat because most anticancer therapeutics do not readily penetrate into the brain due to the tight control at the cerebrovascular